Cargando…

IL-10 and integrin signaling pathways are associated with head and neck cancer progression

BACKGROUND: Head and neck cancer is morbid with a poor prognosis that has not significantly improved in the past several decades. The purpose of this study was to identify biological pathways underlying progressive head and neck cancer to inform prognostic and adjuvant strategies. We identified 235...

Descripción completa

Detalles Bibliográficos
Autores principales: Bornstein, Sophia, Schmidt, Mark, Choonoo, Gabrielle, Levin, Trevor, Gray, Joe, Thomas, Charles R., Wong, Melissa, McWeeney, Shannon
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4706689/
https://www.ncbi.nlm.nih.gov/pubmed/26747525
http://dx.doi.org/10.1186/s12864-015-2359-6
_version_ 1782409203227295744
author Bornstein, Sophia
Schmidt, Mark
Choonoo, Gabrielle
Levin, Trevor
Gray, Joe
Thomas, Charles R.
Wong, Melissa
McWeeney, Shannon
author_facet Bornstein, Sophia
Schmidt, Mark
Choonoo, Gabrielle
Levin, Trevor
Gray, Joe
Thomas, Charles R.
Wong, Melissa
McWeeney, Shannon
author_sort Bornstein, Sophia
collection PubMed
description BACKGROUND: Head and neck cancer is morbid with a poor prognosis that has not significantly improved in the past several decades. The purpose of this study was to identify biological pathways underlying progressive head and neck cancer to inform prognostic and adjuvant strategies. We identified 235 head and neck cancer patients in The Cancer Genome Atlas (TCGA) with sufficient clinical annotation regarding therapeutic treatment and disease progression to identify progressors and non-progressors. We compared primary tumor gene expression and mutational status between these two groups. RESULTS: 105 genes were differentially expressed between progressors and nonprogressors (FDR < 0.05). Pathway analyses revealed deregulation (FDR < 0.05) of multiple pathways related to integrin signaling as well as IL-10 signaling. A number of genes were uniquely mutated in the progressor cohort including increased frequency of truncating mutations in CTCF (P = 0.007). An 11-gene signature derived from a combination of unique mutations and differential expression was identified (PAGE4, SMTNL1, VTN, CA5A, C1orf43, KRTAP19-1, LEP, HRH4, PAGE5, SEZ6L, CREB3). This signature was associated with decreased overall survival (Logrank Test; P = 0.03443). Cox modeling of both key clinical features and the signature was significant (P = 0.032) with the greatest prognostic improvement seen in the model based on nodal extracapsular spread and alcohol use alone (P = 0.004). CONCLUSIONS: Molecular analyses of head and neck cancer tumors that progressed despite treatment, identified IL-10 and integrin pathways to be strongly associated with cancer progression. In addition, we identified an 11-gene signature with implications for patient prognostication. Mutational analysis highlighted a potential role for CTCF, a crucial regulator of long-range chromatin interactions, in head and neck cancer progression. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12864-015-2359-6) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-4706689
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-47066892016-01-10 IL-10 and integrin signaling pathways are associated with head and neck cancer progression Bornstein, Sophia Schmidt, Mark Choonoo, Gabrielle Levin, Trevor Gray, Joe Thomas, Charles R. Wong, Melissa McWeeney, Shannon BMC Genomics Research Article BACKGROUND: Head and neck cancer is morbid with a poor prognosis that has not significantly improved in the past several decades. The purpose of this study was to identify biological pathways underlying progressive head and neck cancer to inform prognostic and adjuvant strategies. We identified 235 head and neck cancer patients in The Cancer Genome Atlas (TCGA) with sufficient clinical annotation regarding therapeutic treatment and disease progression to identify progressors and non-progressors. We compared primary tumor gene expression and mutational status between these two groups. RESULTS: 105 genes were differentially expressed between progressors and nonprogressors (FDR < 0.05). Pathway analyses revealed deregulation (FDR < 0.05) of multiple pathways related to integrin signaling as well as IL-10 signaling. A number of genes were uniquely mutated in the progressor cohort including increased frequency of truncating mutations in CTCF (P = 0.007). An 11-gene signature derived from a combination of unique mutations and differential expression was identified (PAGE4, SMTNL1, VTN, CA5A, C1orf43, KRTAP19-1, LEP, HRH4, PAGE5, SEZ6L, CREB3). This signature was associated with decreased overall survival (Logrank Test; P = 0.03443). Cox modeling of both key clinical features and the signature was significant (P = 0.032) with the greatest prognostic improvement seen in the model based on nodal extracapsular spread and alcohol use alone (P = 0.004). CONCLUSIONS: Molecular analyses of head and neck cancer tumors that progressed despite treatment, identified IL-10 and integrin pathways to be strongly associated with cancer progression. In addition, we identified an 11-gene signature with implications for patient prognostication. Mutational analysis highlighted a potential role for CTCF, a crucial regulator of long-range chromatin interactions, in head and neck cancer progression. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12864-015-2359-6) contains supplementary material, which is available to authorized users. BioMed Central 2016-01-08 /pmc/articles/PMC4706689/ /pubmed/26747525 http://dx.doi.org/10.1186/s12864-015-2359-6 Text en © Bornstein et al. 2016 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Bornstein, Sophia
Schmidt, Mark
Choonoo, Gabrielle
Levin, Trevor
Gray, Joe
Thomas, Charles R.
Wong, Melissa
McWeeney, Shannon
IL-10 and integrin signaling pathways are associated with head and neck cancer progression
title IL-10 and integrin signaling pathways are associated with head and neck cancer progression
title_full IL-10 and integrin signaling pathways are associated with head and neck cancer progression
title_fullStr IL-10 and integrin signaling pathways are associated with head and neck cancer progression
title_full_unstemmed IL-10 and integrin signaling pathways are associated with head and neck cancer progression
title_short IL-10 and integrin signaling pathways are associated with head and neck cancer progression
title_sort il-10 and integrin signaling pathways are associated with head and neck cancer progression
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4706689/
https://www.ncbi.nlm.nih.gov/pubmed/26747525
http://dx.doi.org/10.1186/s12864-015-2359-6
work_keys_str_mv AT bornsteinsophia il10andintegrinsignalingpathwaysareassociatedwithheadandneckcancerprogression
AT schmidtmark il10andintegrinsignalingpathwaysareassociatedwithheadandneckcancerprogression
AT choonoogabrielle il10andintegrinsignalingpathwaysareassociatedwithheadandneckcancerprogression
AT levintrevor il10andintegrinsignalingpathwaysareassociatedwithheadandneckcancerprogression
AT grayjoe il10andintegrinsignalingpathwaysareassociatedwithheadandneckcancerprogression
AT thomascharlesr il10andintegrinsignalingpathwaysareassociatedwithheadandneckcancerprogression
AT wongmelissa il10andintegrinsignalingpathwaysareassociatedwithheadandneckcancerprogression
AT mcweeneyshannon il10andintegrinsignalingpathwaysareassociatedwithheadandneckcancerprogression